Menu Close

Why BioNTech Stock Was Blasting 20% Higher This Week

view original post

[unable to retrieve full-text content]Still a front-line soldier in the war against the resurgent coronavirus, BioNTech (NASDAQ:BNTX) was very much on investors’ radar this week. Comirnaty, the COVID vaccine it’s developed with U.S.